CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) Financials
Annual revenue, profitability and per-share results for CHARLES RIVER LABORATORIES INTERNATIONAL, INC., as reported in SEC filings.
Revenue • FY2025
$4.02B
▼ 0.9%YoY
Net income • FY2025
-$144.34M
▼ 750.1%YoY
Diluted EPS • FY2025
$-2.91
▼ 1555.0%YoY
Annual income statement
| Period | Revenue | Net income | Gross profit | Dil. EPS | Free cash flow | Op. margin | Rev. growth |
|---|---|---|---|---|---|---|---|
| FY2025 | $4.02B | -$144.34M | — | $-2.91 | $518.49M | 0.6% | -0.9% |
| FY2024 | $4.05B | $22.2M | — | $0.20 | $501.61M | 5.6% | -1.9% |
| FY2023 | $4.13B | $474.62M | — | $9.22 | $365.37M | 14.9% | +3.9% |
| FY2022 | $3.98B | $486.23M | — | $9.48 | $294.91M | 16.4% | +12.3% |
Figures as reported in CHARLES RIVER LABORATORIES INTERNATIONAL, INC.'s 10-K filings on SEC EDGAR. Fiscal years may differ from calendar years.
Never miss a CRL filing.
Get an email when CRL files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.